Sign Out
Although there was no evidence of teratogenicity, the use of fluoxetine during pregnancy, especially during the first three months, should be avoided unless it is considered absolutely necessary and the potential benefit outweighs the potential hazards to the fetus.
The use of fluoxetine during breast feeding is not recommended.
Small amounts of fluoxetine are excreted in breast milk; a concentration of 70.4 ng/ml of fluoxetine and norfluoxetine in breast milk was reported. Maternal plasma concentration was 295.0 ng/ml. Although no adverse events were recorded in the child.
Continue with Google